A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats

Journal of the American College of Nutrition

Volumn 23, Issue 5, 2004, Pages 538S-540S

  Vink, Robert ^a   Donkin, J J ^a   Cruz, M I ^c   Nimmo, Alan J ^b   Cernak, Ibolja ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain Mg; Brain trauma; Functional outcome; Inflammation; Rats; Substance P antagonist

Indexed keywords

DRUG DERIVATIVE; MAGNESIUM; N ACETYLTRYPTOPHAN; N-ACETYLTRYPTOPHAN; PROTEINASE INHIBITOR; SUBSTANCE P; TRYPTOPHAN;

ANIMAL; ARTICLE; BRAIN INJURY; DRUG ANTAGONISM; HOMEOSTASIS; MAGNESIUM DEFICIENCY; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN INJURIES; HOMEOSTASIS; MAGNESIUM; MAGNESIUM DEFICIENCY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P; TRYPTOPHAN;

EID: 16644368140     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2004.10719398     Document Type: Article

References (23)

1. Graham DI, Adams JH, Doyle D: Quantification of primary and secondary lesions in severe head injury. Acta Neurochir 57 (Suppl):41–48, 1993.
2. McIntosh TK: Neurochemical sequelae of traumatic brain injury. Cereb Brain Metab Rev 6:109–162, 1994.
3. Vink R, Cernak I: Regulation of brain intracellular free magnesium following traumatic injury to the central nervous system. Front Biosci 5:656–665, 2000.
4. Heath DL, Vink R: Optimization of magnesium therapy following severe diffuse axonal brain injury in rats. J Pharmacol Exp Ther 288:1311–1316, 1999.
5. Bareyre FM, Saatman KE, Raghupathi R, McIntosh TK: Postinjury treatment with magnesium chloride attenuates cortical damage after traumatic brain injury in rats. J Neurotrauma 17:1029–1039, 2000.
6. Saatman KE, Bareyre FM, Grady MS, McIntosh TK: Acute cytoskeletal alterations and cell death induced by experimental brain injury are attenuated by magnesium treatment and exacerbated by magnesium deficiency. J Neuropathol Exp Neurol 60:183–194, 2001.
7. Vink R: Nuclear magnetic resonance characterization of secondary mechanisms following traumatic brain injury. Molec Chem Neuropath 18:279–297, 1993.
8. Nimmo AJ, Cernak I, Heath DL, Hu X, Bennett CJ, Vink R: Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides 38:40–47, 2004.
9. Kramer JH, Phillips TM, Weglicke WB: Magnesium deficiency enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade. J Cardiol 29:97–110, 1997.
10. Vink R, Hu X, Bennett C, Cernak I, Nimmo AJ: Inhibition of neurogenic inflammation improves motor and cognitive outcome following diffuse traumatic brain injury. Rest Neurol Neurosci 16:164, 2000.
11. Cernak I, Vink R, Zapple DN, Cruz MI, Ahmed F, Chang T, Fricke ST, Faden AI: Characterization of a highly adaptable, new model of diffuse traumatic brain injury in rodents. Neurobiol Dis, in press, 2004.
12. Walsh DT, Weg VB, Williams TJ, Nourshargh S: Substance Pinduced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators. Brit J Pharmacol 114:1342–1350, 1995.
13. Vink R, Nimmo AJ: Novel therapies in development for the treatment of traumatic brain injury. Expert Opin Invest Drugs 11:1–12, 2002.
14. Rupniak NM, Kramer MS: Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 20:485–490, 1999.
15. Huston JP, Hasenohrl RU: The role of neuropeptides in learning: focus on the neurokinin substance P. Behav Brain Res 66:117–127, 1995.
16. Parker D, Zhang W, Grillner S: Substance P modulates NMDA responses and causes long-term protein synthesis-dependent modulation of the lamprey locomotor network. J Neurosci 18:4800-4813, 1998.
17. Bereiter DA, Bereiter DF, Tonnessen BH, Maclean DB: Selective blockade of substance P or neurokinin A receptors reduces the expression of c-fos in trigeminal subnucleus caudalis after corneal stimulation in the rat. Neuroscience 83:525–534, 1998.
18. Esen F, Erdem T, Aktan D, Kalayci R, Cakar N, Kaya M, Telci L: Effects of magnesium administration on brain edema and bloodbrain barrier breakdown after experimental traumatic brain injury in rats. J Neurosurg Anesthesiol 15:119–125, 2003.
19. Smith DH, Okiyama K, Gennarelli TA, McIntosh TK: Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury. Neurosci Lett 157:211–214, 1993.
20. Murck H: Magnesium and effective disorders. Nutr Neurosci 5:375–389, 2002.
21. Nowak L, Bregstovski P, Ascher P, Herbert A, Prochiantz A: Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307:462–465, 1984.
22. Hasenohrl RU, De Souza-Silva MA, Nikolaus S, Tomaz C, Brandao ML, Schwarting RKW, Huston JP: Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34:272–280, 2000.
23. Hokfelt T, Pernow B, Wahren J: Substance P: A pioneer amongst neuropeptides. J Intern Med 249:27–40, 2001.